drugset / Trial / NCT01834963
P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of postoperative hepatic arterial infusion chemotherapy, interferon/fluorouracil versus low-dose cisplatin/fluorouracil, in patients with hepatocellular carcinoma with portal vein tumor thrombus.
Timeline
- Start
- 2013-03
- Primary completion
- 2018-02
- Completion
- 2020-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 20 mg/m2 | Other |
| Subject | fluorouracil | Small molecule | 300 mg/m2 | Other |
| Subject | interferon alfa | Protein / enzyme biologic | 5e+06 iu | Subcutaneous |